Not all ALK fusions act the same: Variants influence treatment success in lung cancer
About 5% of lung adenocarcinomas, one of the most common forms of lung cancer, are driven by a faulty fusion of two genes, EML4 and ALK. This fusion results in different variants, and until now, clinicians have treated all ...
Sep 23, 2025
0
15









